Bayer AG (BAYRY)
5.41
+0.05
(+0.93%)
USD |
OTCM |
Nov 14, 15:59
Bayer Enterprise Value: 10.49B for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 10.49B |
| November 12, 2024 | 11.35B |
| November 11, 2024 | 14.77B |
| November 08, 2024 | 14.85B |
| November 07, 2024 | 15.32B |
| November 06, 2024 | 14.73B |
| November 05, 2024 | 15.99B |
| November 04, 2024 | 15.99B |
| November 01, 2024 | 16.15B |
| October 31, 2024 | 16.03B |
| October 30, 2024 | 16.19B |
| October 29, 2024 | 16.74B |
| October 28, 2024 | 17.29B |
| October 25, 2024 | 16.90B |
| October 24, 2024 | 16.86B |
| October 23, 2024 | 16.70B |
| October 22, 2024 | 17.01B |
| October 21, 2024 | 17.21B |
| October 18, 2024 | 17.68B |
| October 17, 2024 | 17.66B |
| October 16, 2024 | 17.78B |
| October 15, 2024 | 17.84B |
| October 14, 2024 | 17.45B |
| October 11, 2024 | 17.92B |
| October 10, 2024 | 18.32B |
| Date | Value |
|---|---|
| October 09, 2024 | 18.88B |
| October 08, 2024 | 21.06B |
| October 07, 2024 | 21.57B |
| October 04, 2024 | 21.73B |
| October 03, 2024 | 21.85B |
| October 02, 2024 | 22.40B |
| October 01, 2024 | 22.48B |
| September 30, 2024 | 22.71B |
| September 27, 2024 | 22.75B |
| September 26, 2024 | 21.41B |
| September 25, 2024 | 20.98B |
| September 24, 2024 | 21.34B |
| September 23, 2024 | 20.71B |
| September 20, 2024 | 20.83B |
| September 19, 2024 | 21.18B |
| September 18, 2024 | 20.04B |
| September 17, 2024 | 19.37B |
| September 16, 2024 | 18.78B |
| September 13, 2024 | 18.94B |
| September 12, 2024 | 18.74B |
| September 11, 2024 | 18.90B |
| September 10, 2024 | 19.37B |
| September 09, 2024 | 20.66B |
| September 06, 2024 | 20.90B |
| September 05, 2024 | 21.06B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.49B
Minimum
Nov 13 2024
121.14B
Maximum
Jan 23 2020
55.50B
Average
50.83B
Median
Enterprise Value Benchmarks
| CureVac NV | 394.66M |
| Affimed NV | 30.82M |
| InflaRx NV | 36.03M |
| BioNTech SE | 8.336B |
| Immatics NV | 314.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -36.61M |
| Revenue (Quarterly) | 12.00B |
| Total Expenses (Quarterly) | 11.43B |
| EPS Diluted (Quarterly) | -0.0081 |
| Gross Profit Margin (Quarterly) | 55.19% |
| Profit Margin (Quarterly) | -0.31% |
| Earnings Yield | -6.54% |
| Operating Earnings Yield | 48.75% |
| Normalized Earnings Yield | -6.538 |